Search results
CoaChrom® Factor XIIa
Measurement of factor XIIa‐like activity in human plasma. For research use only.
CoaChrom® Prothrombin
Assay proposed for the measurement of prothrombin (Factor II) in research applications.
CoaChrom® Prothrombin -> SEE NEW REF. 400001
Assay proposed for the measurement of prothrombin (Factor II) in research applications.
COAMATIC® Faktor VIII
Chromogenic kit for the determination of factor VIII activity
COAMATIC® HEPARIN
COATEST® HEPARIN
Collagen
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome, storage pool disease) or acquired thrombopathy (e.g. myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDs and GPIIb/IIIa inhibitors.
Corn Trypsin Inhibitor (CTI)
FXIIa inhibitor.
CRYOcheck Chromogenic Factor IX
This chromogenic assay is intended to be used as an aid in the management of hemophilia B in individuals aged two years or older. With a limit of quantification of 0.7% FIX activity and a test range of 0–200% FIX CRYO check Chromogenic Factor IX provides unsurpassed assurance in results, especially in cases of patients with severe hemophilia B.
CRYOcheck Chromogenic Factor VIII, frozen
Intended to be used as an aid in the management of hemophilia A in individuals aged two years or older. With a limit of quantification of 0.5% FVIII activity and a test range of 0–200% FVIII using one standard curve, CRYOcheck Chromogenic Factor VIII provides very good assurance in results, especially in cases of patients with severe hemophilia A.